Early Metformin Cuts Long COVID Risk
(MedPage Today) -- Early treatment with metformin reduced the risk of long COVID among outpatients, according to secondary results of a negative phase III trial.
In the COVID-OUT study of over 1,100 randomized participants, the cumulative incidence... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 8, 2023 Category: American Health Source Type: news
Popular diabetes drug promotes weight loss and reverses aging - while also causing severe diarrhea
The inexpensive diabetes medication metformin, the most popular diabetes drug globally, is used off label for weight loss though it carries a hihgly disruptive side effect: explosive diarrhea. (Source: the Mail online | Health)
Source: the Mail online | Health - March 7, 2023 Category: Consumer Health News Source Type: news
New Diabetes Drugs Like Ozempic Are Changing How Patients Are Treated
Metformin, which was first approved in the U.S. in 1995, lowered high blood-sugar levels, studies found. The way doctors treat diabetes is changing. For years, people with Type 2 diabetes who needed to take drugs to lower their blood-sugar levels started with an old medicine called metformin. New…#metformin (Source: Reuters: Health)
Source: Reuters: Health - March 5, 2023 Category: Consumer Health News Source Type: news
Metformin Linked to Reductions in COVID-19 Viral Load Metformin Linked to Reductions in COVID-19 Viral Load
The latest in emerging data on metformin in COVID shows benefits in viral load.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 22, 2023 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Mayo study uses electronic health record data to assess metformin failure risk, optimize care
A recent Mayo Clinic study published in The Journal of Clinical Endocrinology& Metabolism has found that using machine learning and electronic health record (EHR) data can help pinpoint patients with Type 2 diabetes who are at high-risk of experiencing metformin failure. Metformin is a widely used medication for treating diabetes; however, it is not always effective in controlling blood sugar levels. Although it is the first line of therapy used for treatment, metformin has… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 10, 2023 Category: Databases & Libraries Source Type: news
Association of metformin use with fracture risk in type 2 diabetes: a systematic review and meta-analysis of observational studies - Wang Y, Yu L, Ye Z, Lin R, Sun ARJ, Liu L, Wei J, Deng F, Zhong X, Cui L, Li L, Liu Y.
AIMS: Increasing evidence suggests that metformin can affect bone metabolism beyond its hypoglycemic effects in diabetic patients. However, the effects of metformin on fracture risk in type 2 diabetes mellitus (T2DM) patients remain unclear. A systematic r... (Source: SafetyLit)
Source: SafetyLit - February 6, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Metformin Monotherapy Not Always Best Start in Type 2 Diabetes Metformin Monotherapy Not Always Best Start in Type 2 Diabetes
Findings suggest that at time of type 2 diabetes diagnosis some might not benefit from metformin as first-line treatment. Dual or other therapy may be preferable.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 16, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
NPPA revises ceiling prices of 128 formulations
The National Pharmaceutical Pricing Authority (NPPA) has also fixed the retail price of 12 scheduled formulations under Drugs (Prices Control) Order, 2013 (NLEM 2022). The retail price of one tablet of anti-diabetes combination drug Glimepiride, Voglibose& Metformin (extended release) has been fixed at Rs 13.83. Similarly, retail price of one tablet of Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride and Caffeine has been fixed at Rs 2.76. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 16, 2023 Category: Pharmaceuticals Source Type: news
Costs of 127 medicines set to go down post NPPA's 5th price cap
Among the 127 medications on the NPPA's list are paracetamol, amoxycillin, rabeprazole, and metformin. Patients frequently make use of many of these. The price of paracetamol (650 mg), which is sold for Rs 2.3 per tablet, has been restricted at Rs 1.8. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 22, 2022 Category: Pharmaceuticals Source Type: news
Can Metformin Lower Need for Joint Replacement in Diabetes? Can Metformin Lower Need for Joint Replacement in Diabetes?
Patients with type 2 diabetes who were treated with metformin had a 30% reduction in risk for total knee and total hip replacement, compared with patients who did not receive the drug.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 20, 2022 Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news
Metformin Use Linked to Lower Risk for Joint Replacement in T2DM
MONDAY, Dec. 19, 2022 -- For patients with type 2 diabetes, metformin use is associated with a reduced risk for total knee replacement (TKR) and total hip replacement (THR), according to a study published online Dec. 19 in CMAJ, the journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 19, 2022 Category: Pharmaceuticals Source Type: news
Metformin Protective Against Joint Replacement in Type 2 Diabetes
(MedPage Today) -- Among people with type 2 diabetes, use of metformin might help to stave off total joint replacement, a population-based cohort study showed.
Among over 40,000 patients, daily metformin was associated with a 30% lower risk for... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 19, 2022 Category: Urology & Nephrology Source Type: news
Torrent Pharmaceuticals partner with Boehringer Ingelheim to co-market diabetes, cardiovascular medicines
Both companies entered into partnership for the sales and co-marketing of Empagliflozin and its combinations including Cospiaq (Empagliflozin), Cospiaq MetTM (Empagliflozin+ Metformin) and Xilingio (Empagliflozin+ Linagliptin) in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 14, 2022 Category: Pharmaceuticals Source Type: news
R-Form Verapamil Added to Ongoing Metformin Therapy in T2D R-Form Verapamil Added to Ongoing Metformin Therapy in T2D
A new study examines the potential of this combination therapy as a treatment option for patients with type 2 diabetes who do not adequately respond to metformin alone.Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Diabetes Drug Metformin Might Keep Severe COVID Away
WEDNESDAY, Nov. 23, 2022 -- A century-old diabetes drug seems to help keep high-risk COVID-19 patients from falling deathly ill, a new study reports.
Metformin reduced the risk of death from COVID-19 by 44% in a group of diabetics who were taking... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 23, 2022 Category: General Medicine Source Type: news
